On August 29, 2017, Ampio Pharmaceuticals, Inc. announced that it had appointed Thomas E. Chilcott, III, the company's interim Chief Financial Officer, as Chief Financial Officer effective as of August 16, 2017. Prior to joining the Company, Mr. Chilcott, 49, served as the President and Chief Financial Officer of Chilcott Consulting Group from September 2006 to December 2016. Mr. Chilcott has served as the Company's interim Chief Financial Officer since June 11, 2017.